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Abstract
Background: Depressive symptoms are associated with increased incident and recurrent cardiovascular events. In 2010, the
American Heart Association published the Life’s Simple 7, a metric for assessing cardiovascular health as measured by 4
health behaviors (smoking, physical activity, body mass index, diet) and 3 biological measures (cholesterol, blood pressure,
glucose). The association between depressive symptoms and the Life’s Simple 7 has not yet been explored.
Methods: Data from 20,093 participants $45 years of age who enrolled in the Reasons for Geographic and Racial
Differences in Stroke (REGARDS) study between 2003 and 2007 and who had complete data available on Life’s Simple 7
components were used for these analyses. The prevalence of ideal, intermediate, and poor health on each Life’s Simple 7
component and total Life’s Simple 7 scores were compared between participants with and without depressive symptoms.
Depressive symptoms were measured using the 4-item Centers for Epidemiologic Studies of Depression scale.
Results: Participants with depressive symptoms were more likely to have poor levels on each of the Life’s Simple 7
components other than cholesterol [adjusted prevalence ratios (95% CI): smoking 1.41 (1.29–1.55); physical activity 1.38
(1.31–1.46); body mass index 1.09 (1.04–1.15); diet 1.08 (1.06–1.10); blood pressure 1.11 (1.02–1.21); glucose 1.24 (1.09–
1.41)]. There was a graded association between increasing depressive symptoms and lower total Life’s Simple 7 score.
Conclusion: Depressive symptoms are associated with worse cardiovascular health on the overall Life’s Simple 7 and on
individual components representing both health behaviors and biological factors.
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Introduction
Individuals with elevated depressive symptoms, irrespective of
whether the symptoms meet criteria for a clinical diagnosis of
major depression, are at increased risk for incident and recurrent
cardiovascular events.[1–5] The increased cardiovascular risk
attributable to depressive symptoms may result from unfavorable
cardiovascular health behaviors or shared biological mechanisms
linking depression and cardiovascular disease. [6] While prior
studies have shown that patients with depressive symptoms are less
likely to perform certain cardiovascular health behaviors,[7–9]
studies of the association between depressive symptoms and health
behaviors have been limited by focusing on only one health
behavior (e.g., smoking alone [10]), utilizing non-validated
questions to assess behavior (e.g., ‘‘Are you following a heart
healthy diet?’’ [8]), or being restricted to certain populations such
as post-menopausal women. [5] The association between de-
pressive symptoms and biological measures like blood pressure and
cholesterol is even less clear with some studies finding associa-
tions[11–16], but not others.[17–19].
In 2010, the American Heart Association (AHA) published
a metric for assessing overall cardiovascular health in adults.
[20](See Table 1) This metric is comprised of 4 health behaviors
(cigarette smoking, physical activity, body mass index, and diet)
and 3 biological measures (cholesterol, blood pressure, blood
sugar) of cardiovascular health. These 7 components have been
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labeled Life’s Simple 7 for public health messaging. According to
the metric, persons with all of these factors in the ideal range are
classified as having ‘‘ideal’’ cardiovascular health, and others are
classified as having ‘‘intermediate’’ or ‘‘poor’’ cardiovascular
health depending on whether they have any components in the
intermediate or poor levels. Although this metric was derived
according to a consensus of experts, a lower number of ideal
components on this metric has subsequently been associated with
a higher incidence of cardiovascular disease and higher mortality.
[21–22].
Examining the association between depressive symptoms and
the Life’s Simple 7 may lead to a better understanding of the
mechanisms linking depressive symptoms with cardiovascular
prognosis and may inform public health efforts to improve
cardiovascular disease among vulnerable populations with psy-
chological distress. We therefore compared the prevalence of ideal,
intermediate, and poor levels of Life’s Simple 7 components and
summary scores of health behaviors and biological measures on
the Life’s Simple 7 among participants in the Reasons for
Geographic and Racial Differences in Stroke (REGARDS) study
with and without depressive symptoms. The REGARDS study
provides a broad sample of US adults from which to examine this
association and has a sufficient sample size to test whether
depressive symptoms are differentially associated with individual
components of cardiovascular health.
Methods
Ethics Statement
The organization of REGARDS is comprised of an Operations
Center and Survey Research Unit at the University of Alabama at
Birmingham, a Central Laboratory at the University of Vermont,
Table 1. Definitions of the American Heart Association’s Life’s Simple 7 Componentsa.
Life’s Simple 7 component Definition
Smoking
Ideal Never or quit .12 months











Ideal 4–5 healthy diet criteria
Intermediate 2–3 healthy diet criteria
Poor 0–1 healthy diet criteria
Total cholesterol
Ideal ,200 mg/dl, without medication
Intermediate 200–239 mg/dl or treated to ,200 mg/dl
Poor $240 mg/dl
Blood pressure
Ideal SBP/DBP,120/,80 mmHg, without medication
Intermediate SBP of 120–139 or DBP 80–89 mmHg or treated to SBP/DBP,120/,80 mmHg
Poor SBP$140 or DBP$90 mmHg
Fasting serum glucosed
Ideal ,100 mg/dl, without medication
Intermediate 100–125 mg/dl or treated to ,100 mg/dl
Poor $126 mg/dl
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure.
aAs per Lloyd-Jones et al [20].
bDefinitions of ideal and intermediate levels of physical activity were modified from Lloyd-Jones et al [20] in which ideal level was defined as $150 minutes/week of
moderate intensity activity or $75 minutes/week of vigorous activity and intermediate level was defined as 1–149 minutes/week of moderate intensity activity or 1–74
minutes/week of vigorous intensity activity.
cHealthy diet criteria included: 1) fish consumption $2 servings/week, 2) fruits or vegetables$4.5 cups/day, 3) sodium intake,1500 mg/day, 4) sugar,450 kcal/week,
and 5) fiber/carbohydrate ratio .0.1.
dTo avoid excluding non-fasting participants, the following cut-points were used to classify the glucose component in participants (n = 2,378) who did not fast prior to
their study visit: ideal ,140 mg/dl; intermediate 140–199 mg/dl or treated to ,140 mg/dl; poor $200 mg/dl.
doi:10.1371/journal.pone.0052771.t001
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an Electrocardiogram Reading Center at Wake Forest University,
an in-home exam component provided by Examination Manage-
ment Services Inc. (EMSI), and a medical monitoring and stroke
adjudication center at Alabama Neurological Institute Inc.
Additional oversight for the study is provided by the National
Institute of Neurological Disorders and Stroke (NINDS). Study
methods were reviewed and approved by the Institutional Review
Boards of each of these organizations and by an external
observational study monitoring board appointed by the funding
agency, NINDS. As REGARDS participants were first contacted
by telephone, participants initially provided verbal informed
consent. At subsequent in-home study visits, trained EMSI
personnel reviewed and obtained written informed consent from
the participants.
Study Participants
Between January 2003 and October 2007, 30,239 white and
African American US adults, $45 years of age were enrolled into
the REGARDS study, a population-based cohort study of stroke
incidence and cognitive decline.12 African Americans and
residents from 8 Southern US states that comprise the ‘‘stroke
buckle’’ (coastal plain region of North Carolina, South Carolina,
and Georgia) and the ‘‘stroke belt’’ (remainder of North Carolina,
South Carolina, and Georgia, plus Alabama, Mississippi, Tennes-
see, Arkansas, and Louisiana).were oversampled for inclusion.
Potential participants were identified from commercially available
lists of US residents and were recruited through an initial mailing
followed by telephone contacts. The response rate of 33% and the
cooperation rate of 49% were similar to those obtained in other
large epidemiologic studies. [23].






Age, years 65.1 (9.2) 62.6 (9.5) ,0.001
African American, % 32.0 43.9 ,0.001
Women, % 53.9 70.7 ,0.001
Geographic region, %
Stroke belt 34.2 37.7 ,0.001
Stroke buckle 21.6 23.8
Other 44.2 38.5
Less than high school education, % 8.5 19.2 ,0.001
Annual household income ,$20,000, % 15.4 37.9 ,0.001
History of coronary heart disease, % 16.5 21.2 ,0.001
Medication use, %
Antidiabetes medication use, % 17.5 24.7 ,0.001
Lipid-lowering medication use, % 33.9 36.5 0.021
Antihypertensive medication use, % 50.5 58.8 ,0.001
Antidepressant medication use, % 10.9 26.5 ,0.001
Health behaviors
Current smoker, % 12.6 23.8 ,0.001
Obese (body mass index $30 kg/m2), % 35.3 44.9 ,0.001
Physical activity ,1 time per week, % 31.0 46.3 ,0.001
Diet factors
Fish consumption, grams per week 26.0 (31.4) 26.9 (33.9) 0.306
Sodium intake, mg per day 2264 (1053) 2429 (1188) ,0.001
Sugar, mg per day 261.7 (217.7) 306.2 (256.9) ,0.001
Fruits and vegetables, cups per week 4.4 (2.7) 4.0 (2.6) ,0.001
Fiber/carbohydrate intake ratio 0.082 (0.031) 0.073 (0.029) ,0.001
Biological measures
Total cholesterol, mg/dL 191.8 (39.2) 195.4 (43.1) ,0.001
Systolic blood pressure, mmHg 126.6 (16.1) 127.6 (17.7) 0.017
Diastolic blood pressure, mmHg 76.1 (9.4) 76.7 (10.3) 0.007
Fasting serum glucosec, mg/dL 99.9 (27.7) 104.9 (36.8) ,0.001
aData expressed as mean (SD) unless otherwise specified.
bDepressive symptoms were defined as a score $4 on the 4-item Center for Epidemiologic.
Studies Depression Scale.
cAmong 17,715 participants who fasted overnight prior to their REGARDS in-home study visit.
doi:10.1371/journal.pone.0052771.t002
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Data Collection
Data were collected via computer-assisted telephone interviews
(CATI) and in-home study visits. Data collected using the CATI
included sociodemographics, medical history, depressive symp-
toms, cigarette smoking, and physical activity. Data collected
during in-home study visits included a blood sample, electrocar-
diogram, and pill bottle review to confirm medications. Partici-
pants who reported a history of myocardial infarction (MI),
coronary revascularization, or evidence of prior MI on the in-
home electrocardiogram were classified as having coronary heart
disease (CHD). Food intake was assessed by asking participants to
self-administer the Block 98 Food Frequency Questionnaire (FFQ)
[24,25] and to mail completed forms to the REGARDS co-
ordinating center. Nutrient analysis was conducted by Nutrition-
Quest (www.nutritionquest.com).
Life’s Simple 7
Components of the Life’s Simple 7 include cigarette smoking,
physical activity, diet, BMI, blood pressure, cholesterol and
glucose (Table 1).7 Definitions for the physical activity and glucose
components were modified from those proposed by Lloyd-Jones
et al. [20] to fit the REGARDS data collection instrument.
Specifically, instead of defining ideal physical activity as $150
minutes/week of moderate intensity activity or$70 minutes/week
of vigorous activity, participants were asked ‘‘How many times per
week do you engage in intense physical activity, enough to work
up a sweat?’’ and were classified as ideal, intermediate, and poor if
they performed intense physical activity $4, 1 to 3, and 0 times
per week, respectively. As not all participants fasted prior to the
study visit (n = 2,378), the following cut-points for non-fasting
glucose were added to the glucose definition to retain the
maximum amount of data for the glucose component: ideal
,140 mg/dl; intermediate 140–199 mg/dl or treated to
,140 mg/dl; poor $200 mg/dl. [26] Smoking status was de-
termined by three questions: ‘‘Have you smoked at least 100
cigarettes in your lifetime?’’, ‘‘Do you smoke cigarettes now, even
occasionally?’’, and ‘‘How old were you when you stopped
smoking?’’ Participants who reported never smoking more than
100 cigarettes in their lifetime or who quit smoking more than 12
months ago were categorized as ideal on the smoking component;
participants who had smoked more than 100 cigarettes in their
lifetime, but had stopped smoking #12 months ago were
categorized as intermediate, and participants who had smoked
.100 cigarettes in their lifetime and were actively smoking were
categorized as poor. BMI was calculated using height and weight
as measured during the in-home study visit. Diet was categorized
based on responses to the FFQ. Specifically, diet categorization
depended on the number of the following criteria that were met:
fish consumption $2 servings/week, fruit/vegetables $4.5 cups/
day, sodium intake ,1500 mg/day, sugar ,450 kcal/week, and
fiber/carbohydrate ratio .0.1. Blood pressure was measured as
the average of two systolic and diastolic blood pressure measure-
ments obtained using a standardized protocol. Total cholesterol
was measured using an enzymatic reaction.
Depressive Symptoms
The 4-item Centers for Epidemiologic Studies of Depression
(CESD-4) scale was used to assess depressive symptoms. [27] The
scale is comprised of items which assess how many days in the
prior week participants felt depressed, felt lonely, had crying spells,
and felt sad. Response options for each item include: less than
1 day (0 points), 1–2 days (1 point), 3–4 days (2 points), and 5–
7 days (3 points). Each item is scored individually and then items
are summed such that the total score can range from 0 to 12
points. Participants with a CESD-4 score $4 points were
categorized as having depressive symptoms. This cut-point has
79% sensitivity and 86% specificity for identifying clinically
significant depressive symptoms as measured by the full 20-item
CESD scale (i.e., CESD-20 scores $16). [28] Participants were
Figure 1. Distribution of Life’s Simple 7 Components as Ideal,
Intermediate and Poor Among REGARDS Participants With and
Without Elevated Depressive Symptomsa. aDepressive symptoms
were defined as a score $4 on the 4-item Center for Epidemiologic
Studies Depression Scale.
doi:10.1371/journal.pone.0052771.g001
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also categorized into three groups of increasing depressive
symptom severity: minimal depressive symptoms (CESD-4 of
,4); mild-moderate depressive symptoms (CESD-4 of 4 to ,8);
and moderate-severe depressive symptoms (CESD-4 of $8).
Statistical Analyses
Participants were excluded from the present analysis if they had
missing information on one or more Life’s Simple 7 components
(n = 9,931). The most common component with missing in-
formation, accounting for 85% of those excluded, was diet as
many participants did not return the FFQ. An additional 215
participants were excluded because they did not complete the
CESD-4. After these exclusions, there were 20,093 participants
with data for the analyses presented below. Those excluded due to
missing information were similar to those included with respect to
mean age (65 years) and gender (54% women). Those excluded
were more likely to be African American (58%) and to have
depressive symptoms (14%).
Demographic and cardiovascular health characteristics were
compared for REGARDS study participants with and without
depressive symptoms using t-tests and chi-square tests, as
appropriate. Prevalence ratios for having an ideal level of each
Life’s Simple 7 component in those with compared to those
without depressive symptoms were calculated using Poisson
regression models with robust standard error estimates. [29] Also,
prevalence ratios for having $2, $3, $4 and $5 ideal
components in those with versus without depressive symptoms
were calculated. Finally, prevalence ratios for having poor levels of
each Life’s Simple 7 component were calculated. Prevalence ratios
were adjusted for age, race, sex, geographic region of residence,
income, and education.
Each Life’s Simple 7 component was also assigned a score of 1,
2, or 3 points to represent poor, intermediate, or ideal health,
respectively. The assignment to one of these 3 categories was made
in accordance with the recommendations of the developers of the
Life’s Simple 7 (Table 1). The points were summed such that the
total Life’s Simple 7 score could range from 7 (all components
poor) to 21 (all components ideal). Additionally, sub-scores were
summed separately for the 4 health behaviors and the 3 biological
measures. T-tests were used to compare total Life Simple 7 scores
and sub-scores among individuals with and without depressive
symptoms. Additionally, mean differences in these scores were
compared between individuals with and without depressive
symptoms after adjustment for age, race, sex, geographic region
of residence, education and income using linear regression models.
To determine if a graded association was present between severity
of depressive symptoms and Life’s Simple 7 scores, adjusted
differences in the scores were calculated for participants with
CESD-4 scores of ,4, 4 to ,8 and $8. To determine whether
antidepressant use influenced Life’s Simple 7 scores, Life’s Simple
7 scores were compared among participants taking and not taking
antidepressants. Finally, to test whether the association between
depressive symptoms and Life’s Simple 7 scores differed by CHD
status a multiplicative interaction term (CHD * depressive
symptoms) was included in the model. Analyses were conducted
using SAS 9.2 (SAS Institute, Cary, NC).
Results
Participant Characteristics
Participants in this analysis had a mean age of 65 years, 56%
were women, and 33% were African American. The prevalence of
participants with elevated depressive symptoms in the sample was
9.8%. Compared to those without depressive symptoms, partic-
ipants with depressive symptoms were younger, more likely to be
women, and more likely to be African American, live in the
Figure 2. Number of Poor Life’s Simple 7 Components for
REGARDS Study Participants with and without Depressive
Symptoms.
doi:10.1371/journal.pone.0052771.g002
Table 3. Adjusted Prevalence Ratios for Poor Levels of Life’s Simple 7 Components for Participants With Compared to those
Without Depressive Symptoms*.
Life’s Simple 7 Component at Poor Level
Prevalence Ratios
(95% Confidence Interval) P-Value
Smoking (Current) 1.41 (1.29–1.55) ,0.001
Physical Activity (none) 1.38 (1.31–1.46) ,0.001
Diet (,2 out of 5 healthy diet criteria) 1.08 (1.06–1.10) ,0.001
Body mass index (BMI) (BMI $30 kg/m2) 1.09 (1.04–1.15) 0.001
Cholesterol ($240 mg/dL) 1.05 (0.93–1.18) 0.436
Blood pressure (systolic/diastolic $140/$80 mmHg) 1.11 (1.02–1.11) 0.012
Glucose (fasting $126 mg/dL or non-fasting $200 mg/dL) 1.24 (1.09–1.41) ,0.001
*Prevalence ratios are for having poor levels versus intermediate or ideal levels of Life’s Simple 7 components comparing those with versus those without depressive
symptoms. Prevalence ratios are adjusted for age, race, sex, geographic region of residence, education and income. Depressive symptoms are defined as a score $4 on
the 4-item Center for Epidemiologic Studies Depression Scale.
doi:10.1371/journal.pone.0052771.t003
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‘‘stroke belt’’ or ‘‘stroke buckle’’, have less than high school
education, and have a household income ,$20,000 per year
(Table 2). Additionally, those with depressive symptoms were more
likely to be taking medications for hyperlipidemia, diabetes, and
hypertension, and they had a higher prevalence of CHD (Table 2).
Depressive Symptoms and Cardiovascular Health
Participants with depressive symptoms were more likely to have
poor levels of each component (Figure 1) and these differences
were significant for each component other than cholesterol on
adjusted comparisons (Table 3). These associations were strongest
for smoking and physical activity; participants with elevated
depressive symptoms were 41% more likely to be active smokers
and 38% more likely to not be performing any intense physical
activity. Participants with depressive symptoms were also more
likely to have multiple Life’s Simple 7 components in the poor
range (Figure 2). Conversely, participants with depressive
symptoms were less likely to have ideal levels of each component
in unadjusted comparisons (Figure 1). These differences were
significant (p,0.05) after adjustment for each component other
than diet and BMI with adjusted prevalence ratios (95% CI)
ranging from 0.76 (0.70–0.83) for ideal physical activity to 0.93
(0.89–0.97) for glucose. Of note, no participants met the ideal
criteria for diet.
Participants with depressive symptoms had lower scores (i.e.,
worse cardiovascular health) on the total Life’s Simple 7 and on
the health behavior and biological measures sub-scales (Table 4).
Also, there was a graded association between increasing depressive
symptom severity and lower Life’s Simple 7 scores (Table 5).
There was a larger difference in scores between participants
with and without depressive symptoms on the health behavior sub-
scales than on the biological sub-scales. This difference was larger
than could be expected solely as a result of their being one fewer
item on the biological sub-scale. The finding was more prominent
when comparing those with more severe depressive symptoms
(CESD-4$8) to those without depressive symptoms (CESD-4,4).
For this comparison, there was a 1 point difference between
depressed and non-depressed participants on the health behavior
sub-scale as compared to only a 0.4 point difference on the
biological measure sub-scale (Table 5).
Table 4. Life’s Simple 7 Total Score, and Health Behavior and Biological Factor Subscores and Adjusted Differences in Scores






Life’s Simple 7 Scale (7-Item; 7–21 points)
Total Score, mean (SD) 14.6 (2.0) 13.7 (2.1) ,0.001
Adjusted differencea, mean (SE) 0 (ref) 20.63 (0.05) ,0.001
Health Behavior Subscale (4-Item; 4–12 points)
Subscore, mean (SD) 7.9 (1.4) 7.2 (1.4) ,0.001
Adjusted difference, mean (SE) 0 (ref) 20.47 (0.03) ,0.001
Biological Measures Subscale (3-Item; 3–9 points)
Subscore, mean (SD) 6.8 (1.2) 6.6 (1.3) ,0.001
Adjusted difference{, mean (SE) 0 (ref) 20.15 (0.03) ,0.001
Abbreviations: SD, standard deviation; SE, standard error.
aScores were adjusted for age, race, sex, geographic region of residence, education, and income.
bDepressive symptoms were defined as a score $4 on the 4-item Center for Epidemiologic.
Studies Depression Scale.
doi:10.1371/journal.pone.0052771.t004








Life’s Simple 7 Scale (7-Item; 7–21 points)
Total Score, mean (SD) 14.6 (2.0) 13.9 (2.1) 13.3 (2.1)
Adjusted differencea, mean (SE) 0 (ref) 20.54 (0.05) 20.95 (0.10)
Health Behavior Subscale (4-Item; 4–12 points)
Subscore, mean (SD) 7.9 (1.4) 7.3 (1.4) 6.9 (1.4)
Adjusted differencea, mean (SE) 0 (ref) 20.42 (0.04) 20.66 (0.07)
Biological Measures Subscale (3-Item; 3–9 points)
Subscore, mean (SD) 6.8 (1.2) 6.6 (1.3) 6.4 (1.3)
Adjusted differencea mean (SE) 0 (ref) 20.12 (0.03) 20.28 (0.06)
Abbreviations: CESD, 4-item Center for Epidemiologic Studies Depression Scale; SD, standard deviation; SE, standard error.
aScores were adjusted for age, race, sex, geographic region of residence, education, and income.
doi:10.1371/journal.pone.0052771.t005
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Sensitivity Analyses
Depressive symptoms were associated with lower Life’s Simple 7
scores irrespective of whether participants were taking antidepres-
sant medications. In the subgroup of participants with depressive
symptoms, those taking antidepressants had lower Life’s Simple 7
scores than those not taking antidepressants (13.3 points versus
13.9 points, respectively; p,0.001). Similarly, in the subgroup of
participants without depressive symptoms, those who were taking
antidepressants had lower Life’s Simple 7 scores (14.2 points versus
14.7 points; p,0.001).
Finally, depressive symptoms were associated with lower Life’s
Simple 7 scores in both those with and without pre-existing CHD.
The adjusted difference in Life’s Simple 7 score between those
with and without depressive symptoms among those with CHD
was 20.83 (SD 0.11) as compared to 20.68 (SD 0.05) among
those without CHD (p-value for interaction= 0.056).
Discussion
The current analyses demonstrate a strong and graded
association between depressive symptoms and worse cardiovascu-
lar health as measured by the AHA’s Life’s Simple 7. These
associations were present for the total Life’s Simple 7 score and for
having poor and ideal levels of the majority of the individual
components of the metric that represent health behaviors (i.e.,
cigarette smoking, physical activity) and biological measures of
cardiovascular health other than cholesterol (i.e., blood pressure
and glucose).
Depressive symptoms were associated with worse levels on both
behavioral and biological components of the Life’s Simple 7. The
strongest associations were present for smoking and physical
activity: those with depressive symptoms were about 41% more
likely to be active smokers and to be 38% more likely to forego
regular intense physical activity. In contrast, those with depressive
symptoms were not more likely to have poor levels of total
cholesterol and were only modestly more likely to have poor levels
of blood pressure and glucose (24% and 11%, respectively). While
a direct comparison between sub-scores summarizing biological
and behavioral components should be made with caution given
the differing number of items in each sub-score, the finding of
a stronger relationship between depressive symptoms and health
behavior is consistent with prior studies showing that the impact of
psychological distress on cardiovascular risk is more strongly
associated with behavioral factors than biological ones. [30,31 Our
study extends these finding by comprehensively assessing these
relationships in a large, diverse, population-based sample.
Depressive symptoms were common in the REGARDS
population; the 9.8% prevalence in REGARDS is similar to the
9% prevalence of combined major or ‘‘other’’ depression
measured among adults $45 years old in a recent survey of the
US population using a different depression measure. [32]
Accordingly, the impact of depressive symptoms on cardiovascular
health extends to a sizable portion of the population.
The association between depressive symptoms and Life’s Simple
7 score was present in participants with and without preexisting
CHD. This is consistent with prior literature showing that
depressed patients have lower adherence to recommended health
behaviors before and after incident cardiac events. [8,33] Hence, it
will be important to consider the impact of depressive symptoms
on adherence for both primary and secondary cardiovascular
prevention.
The use of antidepressants was associated with lower Life’s
Simple 7 scores (i.e., worse cardiovascular health) among
participants with depressive symptoms. The presence of depressive
symptoms despite taking antidepressant medications may be
indicative of treatment-resistant depression. [34] Accordingly,
our results suggest that treatment-resistant depression may be an
important marker of poor cardiovascular health, and individuals
with this condition may represent a vulnerable group in especially
high need of interventions to improve their cardiovascular health.
An alternative hypothesis is that antidepressant medications may
exert direct adverse effects on health behaviors and biological
factors. For example, some antidepressants have been associated
with weight gain [35] and blood pressure changes. [36] Additional
research into the potentially adverse cardiovascular effects of
antidepressants is warranted.
There are several limitations to the current analysis. The cross-
sectional and observational nature of these data prevent us from
ascribing causal attributions to depressive symptoms on cardio-
vascular health. The CESD-4 measures depressive symptoms
rather than clinical depression and the extrapolation of our results
to patients with clinical depression must be made with caution.
Nevertheless, elevated scores on the CESD-4 have been validated
as a proxy for clinical depression [27] and the prevalence of
depressive symptoms by the CESD-4 in our sample was similar to
the prevalence of depression measured in another population
sample using a different scale. [32] Approximately one-third of
participants were not included due to missing data on the Life’s
Simple 7. As participants with missing data were more likely to
have depressive symptoms, we may have underestimated the true
prevalence of depressive symptoms in this cohort. Further, we had
insufficient information to precisely replicate Life’s Simple 7
metrics for physical activity and glucose. Antidepressants may
have been prescribed for indications other than depression,
limiting the interpretability of the association between antidepres-
sant use and Life’s Simple 7 scores. Finally, REGARDS
recruitment oversampled individuals who were African American
or lived in the stroke belt and participants. Nevertheless, our main
results were adjusted for geographic region and race.
Implications
Our analysis showing worse cardiovascular health according to
the Life’s Simple 7 metric amongst those with depressive
symptoms highlights that depressed individuals are a vulnerable
group in need of special consideration to attain optimal
cardiovascular health on both health behaviors and biological
risks markers. Given the high prevalence of elevated depressive
symptoms in the population, public health efforts to achieve the
AHA 2020 goals of improving cardiovascular health by 20% by
2020 will need to consider approaches to screen for and provide
behavior modification for depressed individuals. Enhanced de-
pression care alone has not consistently resulted in significant
improvements in cardiovascular health behaviors or risk factor
control even when depression was reduced. [37,38] However,
enhanced depression care that is paired with treatment to reach
biological factor goals using a collaborative care approach has
been successful at improving risk factor control in at least one
major study. [39,40] Additional research is needed to identify the
best approaches to achieve ideal cardiovascular health in de-
pressed individuals.
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